Bio-View Ltd (TLV:BIOV)
Israel
· Delayed Price · Currency is ILS · Price in ILA 27.10
+0.30 (1.12%)
May 5, 2025, 12:26 PM IDT
Bio-View Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 25.66 | 34.77 | 29.15 | 30.51 | 25.96 | Upgrade
|
| Revenue Growth (YoY) | -26.21% | 19.29% | -4.48% | 17.54% | -27.47% | Upgrade
|
| Cost of Revenue | 10.09 | 13.39 | 12.48 | 12.93 | 10.18 | Upgrade
|
| Gross Profit | 15.56 | 21.38 | 16.67 | 17.59 | 15.78 | Upgrade
|
| Selling, General & Admin | 11.88 | 12.83 | 11.72 | 9.7 | 8.77 | Upgrade
|
| Research & Development | 6.66 | 8.41 | 4.85 | 5.33 | 5.35 | Upgrade
|
| Other Operating Expenses | 0 | -0.49 | - | - | 0.46 | Upgrade
|
| Operating Expenses | 18.54 | 20.75 | 16.57 | 15.03 | 14.58 | Upgrade
|
| Operating Income | -2.97 | 0.63 | 0.1 | 2.56 | 1.2 | Upgrade
|
| Interest Expense | -0.22 | -0.31 | -0.24 | -0.23 | -0.05 | Upgrade
|
| Interest & Investment Income | 0.39 | 0.44 | 0.03 | 0.02 | 0.04 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.1 | 0.14 | 1.05 | -0.59 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.16 | -0.1 | -0.07 | -0.06 | -0.06 | Upgrade
|
| EBT Excluding Unusual Items | -2.86 | 0.8 | 0.88 | 1.7 | 1.14 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | -0.01 | - | Upgrade
|
| Other Unusual Items | - | - | - | 0.99 | - | Upgrade
|
| Pretax Income | -2.86 | 0.8 | 0.88 | 2.68 | 1.14 | Upgrade
|
| Income Tax Expense | 0.29 | 0.41 | 0.29 | 0.5 | 0.26 | Upgrade
|
| Net Income | -3.15 | 0.38 | 0.59 | 2.18 | 0.88 | Upgrade
|
| Net Income to Common | -3.15 | 0.38 | 0.59 | 2.18 | 0.88 | Upgrade
|
| Net Income Growth | - | -34.75% | -73.12% | 147.06% | -64.99% | Upgrade
|
| Shares Outstanding (Basic) | 133 | 135 | 139 | 140 | 141 | Upgrade
|
| Shares Outstanding (Diluted) | 133 | 135 | 139 | 140 | 141 | Upgrade
|
| Shares Change (YoY) | -1.92% | -2.64% | -0.49% | -0.60% | -0.93% | Upgrade
|
| EPS (Basic) | -0.02 | 0.00 | 0.00 | 0.02 | 0.01 | Upgrade
|
| EPS (Diluted) | -0.02 | 0.00 | 0.00 | 0.02 | 0.01 | Upgrade
|
| EPS Growth | - | -32.99% | -72.99% | 160.43% | -66.27% | Upgrade
|
| Free Cash Flow | -3.14 | -0.12 | 0.51 | 2.59 | 0.5 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.00 | 0.00 | 0.02 | 0.00 | Upgrade
|
| Gross Margin | 60.66% | 61.48% | 57.20% | 57.63% | 60.80% | Upgrade
|
| Operating Margin | -11.59% | 1.81% | 0.35% | 8.38% | 4.63% | Upgrade
|
| Profit Margin | -12.27% | 1.10% | 2.01% | 7.16% | 3.40% | Upgrade
|
| Free Cash Flow Margin | -12.24% | -0.35% | 1.75% | 8.48% | 1.92% | Upgrade
|
| EBITDA | -2.68 | 0.95 | 1.6 | 4.03 | 2.43 | Upgrade
|
| EBITDA Margin | -10.43% | 2.73% | 5.48% | 13.22% | 9.36% | Upgrade
|
| D&A For EBITDA | 0.3 | 0.32 | 1.5 | 1.48 | 1.23 | Upgrade
|
| EBIT | -2.97 | 0.63 | 0.1 | 2.56 | 1.2 | Upgrade
|
| EBIT Margin | -11.59% | 1.81% | 0.35% | 8.38% | 4.63% | Upgrade
|
| Effective Tax Rate | - | 51.94% | 32.91% | 18.60% | 22.52% | Upgrade
|
| Advertising Expenses | 0.22 | 0.12 | 0.17 | 0.04 | 0.11 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.